Iovance Biotherapeutics IOVA
NASDAQ IOVA
$8.79 +0.09 (+1.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Other Non Operating Income (2010 - 2014)

Iovance Biotherapeutics (IOVA) posted quarterly Other Non Operating Income of $1810.0 for Q4 2014, up 196.24% year-over-year from $611.0 in Q4 2013, and up 196.24% quarter-over-quarter from $611.0 in Q4 2013.

Analysis

Iovance Biotherapeutics (IOVA) Other Non Operating Income (2010 - 2014) Analysis & Trends

Iovance Biotherapeutics (IOVA) has reported Other Non Operating Income for 5 consecutive years, with $1810.0 the latest figure, recorded in Q4 2014.

  • In Q4 2014, Other Non Operating Income rose 196.24% year-over-year to $1810.0; the TTM figure through Dec 2014 stood at $6.1 million (down 17.65% YoY), while the FY2025 annual figure was $1.7 million, changed N/A from the prior year.
  • Other Non Operating Income improved to $1810.0 in Q4 2014 per IOVA's latest filing, from $611.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.8 million in Q4 2012 and bottomed at -$4.2 million in Q4 2011.
  • Historically, Other Non Operating Income has averaged $57140.6 across 5 years, with a median of $9214.0 in 2010.
  • On a YoY basis, Other Non Operating Income climbed as much as 52973.02% in 2012 and fell as far as 2906.21% in 2012.
  • Iovance Biotherapeutics' Other Non Operating Income stood at $317503.0 in 2010, then sank by 1412.38% to -$4.2 million in 2011, then soared by 192.38% to $3.8 million in 2012, then plunged by 99.98% to $611.0 in 2013, then surged by 196.24% to $1810.0 in 2014.
  • Business Quant data shows IOVA's Other Non Operating Income at $1810.0 in Q4 2014, $611.0 in Q4 2013, and $3.8 million in Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Iovance Biotherapeutics 3.95 Bn 3.66 Bn 55.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 1,810.00
Sep 30, 2014 4,190.00
Dec 31, 2013 611.00
Dec 31, 2012 5.19 Mn
Sep 30, 2012 953,740.00
Jun 30, 2012 1.32 Mn
Mar 31, 2012 -2.64 Mn
Dec 31, 2011 -4.17 Mn
Sep 30, 2011 -4,337.00
Jun 30, 2011 -398,556.00
Mar 31, 2011 93,954.00
Dec 31, 2010 -245,845.00
Sep 30, 2010 -546,730.00